BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
𝗢𝗡𝗖𝗘 𝗔 𝗥𝗘𝗕𝗘𝗟, 𝗔𝗟𝗪𝗔𝗬𝗦 𝗔 𝗥𝗘𝗕𝗘𝗟 🏠
UNLV Athletics Hall of Famer Nick Garritano has been named the new Head Coach of the Hustlin' Rebels!
🗞️ https://t.co/3UpfpoTwvE
#BEaREBEL
@Jonny_Yutah@MillyGoats@ripheyreb@0and0Sports 100%. Arnold has a lot of talent, so hopefully CDM can figure out the best way to use him, and the rest of the team, to keep on the upward trajectory this year.
That's also possible. I was actually hoping unlv would hop into the Pac conference this go round, but with all the upcoming conference chaos likely to happen, I can understand why they'd try to take a chance and see how it plays out. Unlv football has been on the upswing and its in a good market. Teams love playing here, so its at least a small possibility that they get considered in the next cycle.
@TheZagaholic I didnt say B1G was possible. That's by far the most unlikely scenario with probably zero chances. I'm just saying that their hope/goal is to find a way into any P4 in this next window. If it doesnt happen, then they regroup and figure out what's next.
@gocougs123@UNLVathletics If the money agreed to is a bust, then I'm all for UNLV jumping ship. They stayed based on the deal they got. If the actual amount is much different than anticipated, all bets are off.
@TheZagaholic It depends on how it all shakes out. There's still a lot of unknowns. It's not like I have any say in it anyways. I'm just waiting like everyone else to see what happens.
🚨🚨 Today - 15 individuals have been indicted for over $90 million in an alleged massive healthcare fraud scheme in Minnesota, after a sweeping FBI investigation with @TheJusticeDept and our Interagency Partners.
These charges involve the two LARGEST Medicaid fraud cases ever charged in this district and first-of-their kind charges involving 7 additional Medicaid programs.
As alleged, the defendants defrauded Minnesota public healthcare resources for tens of millions, targeting programs such as Housing Stabilization Services, Child Care, Medicaid programs, Individualized Home Supports (IHS), and more.
In one case, defendants even developed a scheme worth over $40 million to target the Early Intensive Developmental and Behavioral Intervention (EIDBI) – an autism healthcare program - paying kickbacks to parents who fraudulently used autism centers to diagnose children with autism regardless of medical necessity, and billing for services not actually provided. This not only defrauded taxpayers, but robbed valuable resources from families truly in need.
President Trump gave this law enforcement team a mandate to investigate and systematically dismantle this exact kind of public fraud in America – which grossly abuses and mismanages money from hardworking American taxpayers - and that’s exactly what we’re doing. Today’s indictment in a massive moment in this effort.
More to come. @DAGToddBlanche@VP@FBIDDRaia@SecKennedy@DrOzCMS
🚨 BREAKING: The mastermind behind the Feeding Our Future fraud scam in Minnesota has just been sentenced to 41.5 YEARS in prison
Holy CRAP!
Aimee Bock orchestrated the $250 MILLION scam during COVID, billing taxpayers for fake meals for children.
She deserves every single day of this sentence!
MORE OF THIS! 🔥
@tyromper Yep. If those are built at all, they should be done in a location that has a lot of excess water, and preferably, is in a cooler climate. Which basically rules out the entire west part of the US since so much of the water goes into the Colorado river system.